166 related articles for article (PubMed ID: 10393359)
1. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection.
Nair P; Nair KM; Jayaprakash PG; Pillai MR
Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359
[TBL] [Abstract][Full Text] [Related]
2. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
3. Increased angiogenesis in the uterine cervix associated with human papillomavirus infection.
Nair P; Gangadevi T; Jayaprakash PG; Nair MB; Nair MK; Pillai MR
Pathol Res Pract; 1999; 195(3):163-9. PubMed ID: 10220796
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
[TBL] [Abstract][Full Text] [Related]
5. Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Nair P; Jayaprakash PG; Nair MK; Pillai MR
Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656
[TBL] [Abstract][Full Text] [Related]
6. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract][Full Text] [Related]
7. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
8. Cellular manifestations of human papillomavirus infection in the oral mucosa.
Pillai MR; Phanidhara A; Kesari AL; Nair P; Nair MK
J Surg Oncol; 1999 May; 71(1):10-5. PubMed ID: 10362085
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Singh A; Sharma H; Salhan S; Gupta SD; Bhatla N; Jain SK; Singh N
Pathobiology; 2004; 71(6):314-22. PubMed ID: 15627842
[TBL] [Abstract][Full Text] [Related]
10. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of p53 and Bcl-2 proteins in human papillomavirus-induced premalignant lesions of the uterine cervix: correlation with progression to malignancy.
Singh M; Srivastava S; Singh U; Mathur N; Shukla Y
Tumour Biol; 2009; 30(5-6):276-85. PubMed ID: 19940548
[TBL] [Abstract][Full Text] [Related]
12. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
Pillai MR; Nair MK
Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.
Cambruzzi E; Zettler CG; Alexandre CO
Pathol Oncol Res; 2005; 11(2):114-20. PubMed ID: 15999157
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
15. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.
Sultana H; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Sato S; Kamazawa S; Ohwada M; Suzuki M; Terakawa N
Ann Oncol; 2003 Feb; 14(2):214-9. PubMed ID: 12562647
[TBL] [Abstract][Full Text] [Related]
17. Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix.
Bar JK; Markowska J; Harlozińska A; Sedlaczek P; Nowak M; Roszak A
Eur J Gynaecol Oncol; 1996; 17(4):283-5. PubMed ID: 8856306
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha.
Ahmed MI; Salahy EE; Fayed ST; El-Hefnawy NG; Khalifa A
Clin Biochem; 2001 Sep; 34(6):491-8. PubMed ID: 11676979
[TBL] [Abstract][Full Text] [Related]
19. De novo programmed cell death in oral cancer.
Ravi D; Ramadas K; Mathew BS; Nalinakumari KR; Nair MK; Pillai MR
Histopathology; 1999 Mar; 34(3):241-9. PubMed ID: 10217565
[TBL] [Abstract][Full Text] [Related]
20. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
Itakura M; Mori S; Park NH; Bonavida B
Int J Oncol; 2000 Mar; 16(3):591-7. PubMed ID: 10675494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
